Skip to content
ppharmaranks
Menu

FDA Drug Recall Report

pharmaranks analyzed 1,896 FDA drug recalls from Jan 2, 2024 to Sep 15, 2026.Here is what the data shows — how serious the recalls were, why drugs got pulled, and who recalled the most. All figures are computed directly from the U.S. FDA’s openFDA Enforcement database; nothing is estimated.

1,896
recalls analyzed
143
Class I (most serious)
+40%
recalls 2025 vs 2024
385
manufacturers involved

Recalls by year

By recall initiation date. Recalls rose 40% from 2024 to 2025. The current year is partial (data through Sep 15, 2026).

2024557
2025778
2026 (year to date)561

How serious were they? (FDA recall class)

The FDA grades every recall by risk. Class I is the most dangerous — a reasonable probability of serious harm or death.

Class II1,576

May cause temporary or medically reversible harm; low probability of serious harm.

Class III176

Unlikely to cause harm but violates FDA labeling or manufacturing regulations.

Class I143

Most serious — a reasonable probability that use will cause serious harm or death.

Why drugs get recalled

Recall reasons, grouped from the FDA’s free-text reason field. "Manufacturing (CGMP) deviations" led with 565. Manufacturing and contamination problems alone account for 944 (50%).

Manufacturing (CGMP) deviations565
Contamination / sterility379
Potency / dissolution failures255
Particulate / foreign matter195
Impurities / stability161
Other152
Labeling errors99
Packaging / container defects55
Nitrosamine impurity35

Most-recalled manufacturers

Companies with the most recall events in the period (largely generic-drug makers). A high count reflects recall volume, not necessarily overall quality — large generics portfolios recall more.

Glenmark Pharmaceuticals Inc., USA100
GenoGenix LLC57
SUN PHARMACEUTICAL INDUSTRIES INC44
Zydus Pharmaceuticals (USA) Inc41
Amerisource Health Services LLC34
Teva Pharmaceuticals USA, Inc30
ACCORD HEALTHCARE, INC.30
GOLD STAR DISTRIBUTION INC27

The most serious recalls (Class I)

Recent Class I recalls — the FDA’s highest-risk tier.

  • Superpotent DrugVITRUVIAS THERAPEUTICS INC · Aug 21, 2026
  • Presence of Particulate Matter: identified as iron oxideB BRAUN MEDICAL INC · Aug 19, 2026
  • Presence of particulate matter: Particulates identified as fiberglassBaxter Healthcare Corporation · Aug 17, 2026
  • Presence of Particulate Matter: identified as stainless steel particles in the…Baxter Healthcare Corporation · Aug 17, 2026
  • Presence of Particulate matter.B BRAUN MEDICAL INC · Aug 12, 2026

How fast the system responds — and who starts it

The lag from a firm initiating a recall to the FDA publishing it, and how many recalls are voluntary (firm-initiated) rather than FDA-ordered.

28 days
median: recall start → FDA report
100%
voluntary (firm-initiated)
+19%
recalls, latest full month vs prior

Nearly every U.S. drug recall in this data (100%) is voluntary — the manufacturer pulls the product itself, typically under FDA pressure, rather than being formally ordered to. Half reach the public record within 28 days of the firm acting (mean 33).

Methodology & sources

All figures are computed directly from the U.S. FDA’s openFDA drug Enforcement database (1,896 recall records initiated Jan 2, 2024–Sep 15, 2026, covering 385 manufacturers across 42states). Recall reasons are grouped by keyword from the FDA’s free-text field, so categories are approximate; counts by class, year, firm, and status are exact. Many recalls are still “ongoing,” so totals for recent periods will rise. Updated hourly from our live drug recall tracker.

Cite this report:“FDA Drug Recall Report,” pharmaranks, Sep 15, 2026. https://pharmaranks.com/recalls/report

For journalists & researchers: every figure here is derived from the open FDA enforcement dataset and is free to cite and reproduce with attribution and a link. For the methodology or a custom cut of the data, get in touch.